Showing results (221-230 of 377) with videos related to
Sort By:
Pageof 38
Cell Cycle (Georgetown, Tex.)|November 23, 2012
Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cellsFederica Sotgia, Diana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, et al.Journal of Medical Genetics|January 27, 2019
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer casesRobert D Morgan, George J Burghel, Nicola Flaum, et al.Cancers|February 11, 2023
Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?Robert D Morgan, George J Burghel, Nicola Flaum, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 7, 2009
Biomarkers of dietary energy restriction in women at increased risk of breast cancerKai Ren Ong, Andrew H Sims, Michelle Harvie, et al.The Breast Journal|May 20, 2003
A roundtable discussion of aromatase inhibitors as therapy for breast cancerD Craig Allred, Michael Baum, Aman U Buzdar, et al.The Lancet. Oncology|December 9, 2023
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trialJack Cuzick, Kim Chu, Brian Keevil, et al.British Journal of Cancer|March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?Robert D Morgan, George J Burghel, Nicola Flaum, et al.Cell Cycle (Georgetown, Tex.)|January 12, 2012
Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolismAdam Ertel, Aristotelis Tsirigos, Diana Whitaker-Menezes, et al.Cancer Biology & Therapy|September 24, 2010
Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environmentMichael P Lisanti, Ubaldo E Martinez-Outschoorn, Barbara Chiavarina, et al.Cell Cycle (Georgetown, Tex.)|August 25, 2012
Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growthValentina Carito, Gloria Bonuccelli, Ubaldo E Martinez-Outschoorn, et al.Pageof 38